Kay AH, et al. - Researchers examined complications in correlation with intraperitoneal (IP) ports placed concurrently with bowel resection during surgical treatment of ovarian cancer vs those ports placed without concurrent bowel resection. They grouped the 306 patient who had an IP port placed at their institution between 2005 and 2016, into two: IP ports placed with bowel resection (IP-BR) and those without (IP). Outcomes revealed no higher rate of complications, nor lower rates of IP chemotherapy administration among patients who have IP ports placed concurrently with a bowel resection. Stage IIIC disease was evident in more IP-BR patients (83.3% IP-BR vs 56.9% IP). Patients were cytoreduced to R0 in 48.7% IP-BR vs 56.4% IP. For adjuvant treatment, administration of IV chemotherapy was done before IP chemotherapy in 90.4% IP-BR (median 2 cycles), and 50.3% IP, (median 2 cycles). Ultimately, chemotherapy was administered in 80.2% IP-BR (median 4 cycles) and 77.8% IP (median 5 cycles) patients.